Position in DYN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$4,135,453
-$216,647 QoQ
Shares Held
228,100
+2.5% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss National Bank holds $1,641,068,486 across 148 Biotechnology names. DYN ranks #60 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,600 | $332,493,684 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
303,140 | $234,218,089 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
387,720 | $128,284,916 | |
| 4 | INSM |
INSMED Inc
|
625,912 | $102,349,130 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,191,100 | $57,137,067 | |
| 6 | INCY |
Incyte Corp
|
489,774 | $46,097,528 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
425,431 | $41,373,164 | |
| 8 | MRNA |
Moderna, Inc.
|
696,100 | $35,361,880 |
All Filings in DYN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,135,453 | 228,100 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,352,100 | 222,500 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,255,495 | 178,300 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,336,608 | 140,400 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,237,418 | 118,300 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,558,616 | 108,600 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,775,192 | 105,100 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,737,211 | 105,900 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,418,828 | 85,200 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $800,660 | 60,200 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $568,960 | 63,500 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $714,375 | 63,500 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $648,576 | 56,300 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $724,375 | 62,500 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $772,160 | 60,800 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $417,696 | 60,800 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $529,236 | 54,900 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $606,390 | 51,000 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $828,240 | 51,000 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,073,040 | 51,000 | Shares | Sole | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||